Work

A Novel BCR::ABL1 Rearrangement Harboring the Gatekeeper Mutation Drives Hyper-Kinase Activity Conferring Resistance to Ponatinib and Asciminib Combination Therapy

Year: 2024

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2024-211279

Authors: Valentina Nardi, Joshua Schwieterman, Zachary Kincaid, Andrew M. Brunner, Maria Reyes, Gabriel K. Griffin, Sekhu Ansari, Mohammad Azam

Institutions: Massachusetts General Hospital, Cincinnati Children's Hospital Medical Center, Harvard University, Dana-Farber Cancer Institute, Broad Institute

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4405038342

Cites:

Cited by: 4

Related to: 10